Journal article
Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure
June Corry, Alisha Moore, Liz Kenny, Chris Wratten, Tsien Fua, Charles Lin, Sandro Porceddu, Chen Liu, Michael Ruemelin, Amy Sharkey, Lachlan Mcdowell, Dean Wilkinson, Albert Tiong, Danny Rischin
Frontiers in Oncology | Frontiers Media S.A. | Published : 2024
Abstract
Introduction: There is no consensus as to what specifically constitutes head and neck cancer radiotherapy quality assurance (HNC RT QA). The aims of this study are to (1) describe the RT QA processes used in the TROG 12.01 study, (2) review the RT QA processes undertaken for all patients with loco-regional failure (LRF), and (3) provide prospective data to propose a consensus statement regarding the minimal components and optimal timing of HNC RT QA. Materials and methods: All patients undergoing RT QA in the original TROG 12.01 study were included in this substudy. All participating sites completed IMRT credentialling and a clinical benchmark case. Real-time (pre-treatment) RT QA was perfor..
View full abstractGrants
Funding Acknowledgements
We thank all the patients who participated, all clinicians who contributed to this study, and TROG staff Patrick Wheeler and Olivia Cook. Merck KGaA, Darmstadt, Germany reviewed the manuscript for medical accuracy only before journal submission.